Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery
Top Cited Papers
Open Access
- 1 October 2006
- Vol. 52 (1) , 33-38
- https://doi.org/10.1016/j.neuron.2006.09.026
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expressionHuman Molecular Genetics, 2006
- Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2006
- α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's ModelsScience, 2006
- Diagnosis and treatment of Parkinson disease: molecules to medicineJournal of Clinical Investigation, 2006
- The Role of Biomarkers in Clinical Trials for Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2006
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005
- Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological studyJournal of Neurology, Neurosurgery & Psychiatry, 2004
- α-synuclein locus duplication as a cause of familial Parkinson's diseasePublished by Elsevier ,2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997